Evidence map›Paper›PMID 41246934›Full record

ArticleJournal of cosmetic dermatology2025

Expert Panel Guidelines for Hybrid CaHA-CMC/CPM-HA Fillers in the Mexican Population.

Victoria de la Fuente García, Susana Sil Zavaleta, María Guadalupe Lozada Arenas, Javier Ruiz Ávila, Socorro Isela Méndez Baca, Jorge Torres García, Alejandro García Balbas, Hiram Rogelio Elizondo Vilchez, Javier Reynoso Vázquez, Randall Alfonso Herrera Lozano and 1 more

Abstract read
In one paragraph

Article in Journal of cosmetic dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Victoria de la Fuente GarcíaLevels High-End Dermatology, Mexico City, Mexico.ORCID https://orcid.org/0009-0001-7769-7892
Susana Sil ZavaletaHands and Skin, Hospital Angeles, Mexico City, Mexico.
María Guadalupe Lozada ArenasClinique D' Ozono, Mexico City, Mexico.
Javier Ruiz ÁvilaDermedica Clinic, Mexico City, Mexico.
Socorro Isela Méndez BacaIsela Mendez Dermatology Clinic, Mexico City, Mexico.
Jorge Torres GarcíaAllure Antiaging Clinic, Saltillo, Mexico.
Alejandro García BalbasDr. AGB Clinic, Queretaro, Mexico.
Hiram Rogelio Elizondo VilchezDr. Hiram Elizondo Clinic, Mexico City, Mexico.
Javier Reynoso VázquezThe Health Center, Puebla, Mexico.
Randall Alfonso Herrera LozanoRH Clinic Leon, Guanajuato, Mexico.
Nabil Fakih-GomezDepartment of Facial Plastic and Cranio-Maxillo-Facial Surgery, Fakih Hospital, Khaizaran, Lebanon.

Funding

Merz Pharmaceuticals
6 · The paper itself

Abstract

introductionCombination of calcium hydroxylapatite-carboxymethylcellulose (CaHA-CMC) and hyaluronic acid (HA) in a single syringe has shown effectiveness and safety. In light of the growing popularity of hybrid fillers in aesthetic medicine, there is a need to establish treatment guidelines, especially focusing on diverse populations, including Mexicans.

methodsBy combining the clinical expertise of 10 Mexican injectors with scientific evidence, recommendations were established for the use of hybrids in treating patients from a Mexican population. The panel reached consensus on 10 topics: skin preparation, anesthetic use, hybrid filler preparation, syringe choice, injection protocol by anatomical zone, duration of treatment, complications/adverse events, patient perspective, treatment costs and future perspectives.

resultsRegardless of the CPM-HA or anatomic area, a 1:1 ratio of CaHA-CMC to CPM-HA, was the preferred ratio for filler preparation and was administered subcutaneously using fanning and retro-injection techniques. Almost all experts (9/10, 90%) believed the clinical outcomes obtained with hybrid fillers and the reduced treatment time (number of visits required) justify the increased cost. Main factors in driving increased adoption of hybrid treatments in clinical practice were high patient satisfaction, clinical efficacy, innovation, and prolonged duration of results. The choice of CPM-HA for the hybrid filler should be guided by skin quality, degree of sagging, volume loss, underlying anatomy, and patient expectations.

conclusionsThis paper provided recommendations regarding the preparation and injection of CaHA-CMC and CPM-HA combinations across different anatomical regions. These contributions aim to support clinical decision-making, optimize outcomes, and improve patient safety in aesthetic treatments.

Indexed as

Carboxymethylcellulose SodiumCosmetic TechniquesDermal FillersDurapatiteHyaluronic AcidSkin AgingHumansInjections, SubcutaneousMexicoPatient SatisfactionPractice Guidelines as TopicCarboxymethylcellulose SodiumDermal FillersDurapatiteHyaluronic AcidCaHACaHA‐CMCcalcium hydroxylapatiteCPMCPM‐HAhyaluronic acidhybrid fillerMexicansrecommendations

Identifiers

PMID41246934
PMCPMC12621286

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.